Absence of first-pass isolation is associated with poor pulmonary vein isolation durability and atrial fibrillation ablation outcomes.

adenosine triphosphate atrial fibrillation durable pulmonary vein isolation first‐pass isolation pulmonary vein reconnection

Journal

Journal of arrhythmia
ISSN: 1880-4276
Titre abrégé: J Arrhythm
Pays: Japan
ID NLM: 101263026

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 22 05 2021
revised: 17 08 2021
accepted: 19 08 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 11 12 2021
Statut: epublish

Résumé

Pulmonary vein (PV) reconnection is the main cause of atrial fibrillation (AF) recurrence. This study aimed to examine the effect of first-pass PV isolation (PVI) on PV reconnection frequency during the procedure and on AF ablation outcomes. This retrospective study included 446 patients with drug-refractory AF (370 men, aged 64 ± 10 years) who underwent initial PVI using an open-irrigated contact force catheter between January 2015 and October 2016. We investigated the effect of first-pass PVI on PV reconnection during spontaneous PV reconnection and dormant conduction after an adenosine triphosphate challenge. First-pass PVI was achieved in 69% (617/892) of ipsilateral PVs, of which we observed PV reconnection during the procedure in 134 (22%) PVs. This value was significantly lower than that observed in those without first-pass PVI (50%, 138/275) ( Absence of first-pass PVI was associated with a higher frequency of spontaneous PV reconnection and dormant conduction and poor ablation outcomes. First-pass isolation may be a useful marker for better PVI durability.

Sections du résumé

BACKGROUND BACKGROUND
Pulmonary vein (PV) reconnection is the main cause of atrial fibrillation (AF) recurrence. This study aimed to examine the effect of first-pass PV isolation (PVI) on PV reconnection frequency during the procedure and on AF ablation outcomes.
METHODS METHODS
This retrospective study included 446 patients with drug-refractory AF (370 men, aged 64 ± 10 years) who underwent initial PVI using an open-irrigated contact force catheter between January 2015 and October 2016. We investigated the effect of first-pass PVI on PV reconnection during spontaneous PV reconnection and dormant conduction after an adenosine triphosphate challenge.
RESULTS RESULTS
First-pass PVI was achieved in 69% (617/892) of ipsilateral PVs, of which we observed PV reconnection during the procedure in 134 (22%) PVs. This value was significantly lower than that observed in those without first-pass PVI (50%, 138/275) (
CONCLUSIONS CONCLUSIONS
Absence of first-pass PVI was associated with a higher frequency of spontaneous PV reconnection and dormant conduction and poor ablation outcomes. First-pass isolation may be a useful marker for better PVI durability.

Identifiants

pubmed: 34887951
doi: 10.1002/joa3.12629
pii: JOA312629
pmc: PMC8637089
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1468-1476

Informations de copyright

© 2021 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society.

Déclaration de conflit d'intérêts

KI received honoraria from Johnson KK and Medtronic, Inc The other authors (YN, NT, KT, TO, YH, TO, MO, HI, KT, RN, RK, YK, AO, KI, MO, and KF) declare no conflicts of interest for this article.

Références

JACC Clin Electrophysiol. 2018 Jan;4(1):99-108
pubmed: 29600792
Front Physiol. 2020 Dec 15;11:594654
pubmed: 33384608
J Cardiol. 2016 Oct;68(4):335-41
pubmed: 26603325
Circulation. 2005 Jan 18;111(2):127-35
pubmed: 15623542
Circulation. 2004 Oct 12;110(15):2090-6
pubmed: 15466640
Int J Cardiol. 2020 Feb 15;301:96-102
pubmed: 31759685
Circ J. 2007 May;71(5):753-60
pubmed: 17457004
Circ J. 2017 Oct 25;81(11):1596-1602
pubmed: 28579576
Circ Arrhythm Electrophysiol. 2012 Apr;5(2):295-301
pubmed: 22042883
Circulation. 2005 Aug 2;112(5):627-35
pubmed: 16061753
Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):691-700
pubmed: 22652692
Heart Rhythm. 2017 Oct;14(10):e275-e444
pubmed: 28506916
Pacing Clin Electrophysiol. 2009 Oct;32(10):1307-12
pubmed: 19796347
Eur Heart J. 2015 Dec 7;36(46):3276-87
pubmed: 26321237

Auteurs

Yuichi Ninomiya (Y)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.
Department of Cardiovascular Medicine and Hypertension Kagoshima University Graduate School of Medical and Dental Sciences Kagoshima Japan.

Koichi Inoue (K)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Nobuaki Tanaka (N)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Masato Okada (M)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Koji Tanaka (K)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Toshinari Onishi (T)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Yuko Hirao (Y)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Takafumi Oka (T)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Hiroyuki Inoue (H)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Kohtaro Takayasu (K)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Ryo Nakamaru (R)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Ryo Kitagaki (R)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Yasushi Koyama (Y)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Atsunori Okamura (A)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Katsuomi Iwakura (K)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Mitsuru Ohishi (M)

Department of Cardiovascular Medicine and Hypertension Kagoshima University Graduate School of Medical and Dental Sciences Kagoshima Japan.

Kenshi Fujii (K)

Cardiovascular Center Sakurabashi Watanabe Hospital Osaka Japan.

Classifications MeSH